Jane Street’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,592
Closed -$497K 9685
2023
Q2
$497K Sell
200,592
-1,539
-0.8% -$3.03K ﹤0.01% 6330
2023
Q1
$295K Buy
202,131
+32
+0% +$59 ﹤0.01% 7229
2022
Q4
$392K Buy
202,099
+10
+0% +$11 ﹤0.01% 6563
2022
Q3
$79K Sell
202,089
-586
-0.3% -$312 ﹤0.01% 8756
2022
Q2
$122K Buy
202,675
+588
+0.3% +$308 ﹤0.01% 8529
2022
Q1
$178K Sell
202,087
-14,556
-7% -$18.5K ﹤0.01% 9112
2021
Q4
$443K Buy
+216,643
New +$331K ﹤0.01% 7480

Jane Street's ROIVW Position: Q3 2023 in Review

Jane Street sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 200,592 shares — an estimated $497K sold.

Jane Street first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $497K in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Jane Street reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 200,592 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $497K.
  • Jane Street first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
  • Jane Street's Roivant Sciences Ltd. Warrant position peaked at $497K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.